James Brady
Förmögenhet: 929 615 $ per 2026-08-31
Förmögenhet: 929 615 $ per 2026-08-31
James P.
Brady is currently Chief Human Resources Officer at Ardelyx, Inc. since 2025.
Formerly, Mr. Brady was Chief Human Resources Officer at Spero Therapeutics, Inc., Vice President-Human Resources at Intarcia Therapeutics, Inc. from 2015 to 2020, and Chief Human Resources Officer at uniQure NV from 2020 to 2021.
Education includes graduate studies at Harvard University and undergraduate studies at Marietta College.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ARDELYX, INC. 0,1 % | 2026-08-21 | 245 930 ( 0,1 % ) | 929 615 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| ARDELYX, INC. | Personalchef | 2025-06-02 |
| Företag | Position | Slut |
|---|---|---|
| UNIQURE N.V. | Personalchef | 2021-09-01 |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Personalchef | 2020-08-01 |
| SPERO THERAPEUTICS, INC. | Personalchef | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Marietta College
Marietta College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Ardelyx, Inc.
Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
uniQure NV
uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Spero Therapeutics, Inc.
Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån